This week we launched our report, Intelligent post-launch patient support: Enhancing patient safety with AI. This is the sixth and final report in our Intelligent biopharma series that highlights the impact of artificial intelligence (AI) across the biopharma value chain, and explores the role of AI in the final step in the value chain, post-market pharmacovigilance (PV) and patient support programmes (PSP).
